Results 131 to 140 of about 412,436 (221)

Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera. [PDF]

Commun Med (Lond)
Li X, An W, Wang X, Yin Z, Gao Y, Lan Y, Zhang L, Zhao B, Chang L, Ruan M, Zhang L, Zou Y, Yang W, Zhu X.   +13 more
europepmc   +1 more source

Complete Hematological Response Coupled with Molecular Response in Polycythemia Vera Treatment with Ropeginterferon Alfa-2b. [PDF]

Life (Basel)
Vecchio V, Cacciola R, Cacciola E.
europepmc   +1 more source

Impact of echocardiographic hemodynamics on outcomes among patients with polycythemia vera or essential thrombocythemia. [PDF]

Cardiooncology
Leiva O, Soo S, Liu OC, You V, Hobbs G.
europepmc   +1 more source

Correction: Case report: Woven-like coronary arteries in a patient with polycythemia vera. [PDF]

BMC Cardiovasc Disord
Wang B, Zhang M, Zhang J, Lu M, Zhang W.
europepmc   +1 more source

Polycythemia vera and stiff-person syndrome: a case report. [PDF]

BMC Neurol
Mu H, Ji F, Du R, Hou L, Li Y, Yang X, Shao C, Hou K, Wang Y.   +8 more
europepmc   +1 more source

NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera. [PDF]

Ann Hematol
Cerchiara E, Cristiano A, Vozella F, Gambaro FL, Iovene FR, Barsotti RM, Ristori MV, De Cesaris M, Rigacci L, Angeletti S.   +9 more
europepmc   +1 more source

Prevalence, incidence, and risk factors of secondary malignancies in patients with polycythemia vera: a real-world study. [PDF]

Blood Adv
Pemmaraju N, Markova A, Masarova L, Reaven N, Funk S, Ferguson TW, Bellamy L, Dinh P, Oyuela P, Valone F, Molina A, Gupta S.   +11 more
europepmc   +1 more source

Ropeginterferon dose-escalation strategies in polycythemia vera: a systematic review and meta-analysis. [PDF]

BMC Cancer
Yoon SY, Park S, Jeong SY, Lee MY, Kim KH, Lee N, Won JH, Lee SE.   +7 more
europepmc   +1 more source

Polycythemia Vera with Incidental Large Aortic Aneurysm and Giant Cell Arteritis: Case Report. [PDF]

Clin Med Insights Case Rep
Obaid K, Sadek K, Al Jaber F, Altermanini M, Al-Mashdali AF, Yassin M, Alkhulaifi AM, Carr CS, Mohamed SF.   +8 more
europepmc   +1 more source

JAK Inhibitor-Induced Improvement of IgA Nephropathy in a Patient With Polycythemia Vera: A Case Report. [PDF]

Kidney Med
Takahashi-Kobayashi M, Nishikii H, Shimizu T, Kaneko Y, Sakata-Yanagimoto M, Usui J.   +5 more
europepmc   +1 more source